See more : Central Reinsurance Corporation (2851.TW) Income Statement Analysis – Financial Results
Complete financial analysis of InNature Berhad (5295.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InNature Berhad, a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Mitek Systems, Inc. (0K1W.L) Income Statement Analysis – Financial Results
- Metagenomi, Inc. Common Stock (MGX) Income Statement Analysis – Financial Results
- Hudbay Minerals Inc. (HBM.TO) Income Statement Analysis – Financial Results
- Menhaden Resource Efficiency PLC (MHN.L) Income Statement Analysis – Financial Results
- Sichuan Anning Iron and Titanium Co.,Ltd. (002978.SZ) Income Statement Analysis – Financial Results
InNature Berhad (5295.KL)
About InNature Berhad
InNature Berhad, an investment holding company, engages in retailing and distribution of cosmetics and personal care products in Malaysia, Vietnam, and Cambodia. It offers skincare, body care, hair care, and make-up products under the Natura, Aesop, and Avon brands. The company distributes its products through retail stores located in shopping malls, high-streets, airport stores, and department stores; and e-commerce websites, as well as third-party online stores. InNature Berhad was founded in 1984 and is headquartered in Subang Jaya, Malaysia. InNature Berhad is a subsidiary of Etheco Sdn Bhd.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 135.33M | 149.40M | 131.92M | 155.36M | 191.68M |
Cost of Revenue | 44.47M | 51.85M | 46.90M | 51.08M | 62.40M |
Gross Profit | 90.86M | 97.55M | 85.02M | 104.28M | 129.28M |
Gross Profit Ratio | 67.14% | 65.29% | 64.45% | 67.12% | 67.44% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 45.04M |
Selling & Marketing | 6.26M | 6.18M | 6.67M | 7.74M | 8.68M |
SG&A | 6.26M | 6.18M | 6.67M | 7.74M | 53.72M |
Other Expenses | 71.50M | 280.00K | 618.00K | 25.00K | 0.00 |
Operating Expenses | 77.76M | 69.97M | 64.38M | 74.89M | 87.06M |
Cost & Expenses | 122.22M | 121.82M | 111.28M | 125.97M | 149.47M |
Interest Income | 1.87M | 931.00K | 1.22M | 923.00K | 407.00K |
Interest Expense | 1.50M | 1.18M | 1.90M | 2.22M | 2.23M |
Depreciation & Amortization | 4.39M | 17.82M | 20.25M | 21.42M | 4.39M |
EBITDA | 17.50M | 31.87M | 42.68M | 51.26M | 49.19M |
EBITDA Ratio | 12.93% | 31.75% | 32.53% | 33.63% | 25.66% |
Operating Income | 13.11M | 27.57M | 21.18M | 29.39M | 44.80M |
Operating Income Ratio | 9.68% | 18.46% | 16.06% | 18.92% | 23.37% |
Total Other Income/Expenses | 703.00K | 1.05M | -652.00K | -1.77M | -4.41M |
Income Before Tax | 13.81M | 28.62M | 20.53M | 27.62M | 40.40M |
Income Before Tax Ratio | 10.20% | 19.16% | 15.56% | 17.78% | 21.07% |
Income Tax Expense | 3.31M | 7.29M | 5.48M | 7.44M | 10.24M |
Net Income | 10.50M | 21.34M | 15.05M | 20.18M | 30.15M |
Net Income Ratio | 7.76% | 14.28% | 11.41% | 12.99% | 15.73% |
EPS | 0.01 | 0.03 | 0.02 | 0.03 | 0.04 |
EPS Diluted | 0.01 | 0.03 | 0.02 | 0.03 | 0.04 |
Weighted Avg Shares Out | 705.88M | 705.88M | 705.88M | 695.94M | 705.88M |
Weighted Avg Shares Out (Dil) | 705.88M | 705.88M | 705.88M | 695.94M | 705.88M |
Source: https://incomestatements.info
Category: Stock Reports